Medtech Insight is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Putting The Pieces Together Again: GSK Creates End-To-End Business Units

Executive Summary

At the forefront of radical R&D reorganization, GlaxoSmithKline continues to evolve its model, characterized to date by the breaking up of R&D into small, biotech-like drug performance units (DPUs). These units are about to undergo the latest round of change: closer integration with the downstream medicines development centers in their respective therapeutic areas. The move makes sense given industry's growing recognition of the need for payor and regulator requirements to inform even early-stage discovery and development.

Related Content

AstraZeneca Rebuilds R&D Amid Growing Near-Term Pressures
Sanofi Reworks R&D To Tackle Risk, Meet Unmet Need
Back To School: Big Pharmas Test New Models For Tapping Academia
Changing Pharma's Innovation DNA
A Look Back At 2010: In Search Of New Biopharma Models
Reenergizing R&D: Sanofi Stirs The Pot, But Does It Have The Recipe?
GSK Spins Out Pain Assets, Raises $35.4m
GSK Tries to Mimic Real-World Biotech
GSK Tries to Mimic Real-World Biotech
Pfizer Restructures For A More Flexible Future


Related Companies

Related Deals




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts